BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Duan X, Iwanowycz S, Ngoi S, Hill M, Zhao Q, Liu B. Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target. Front Oncol 2021;11:629846. [PMID: 33898309 DOI: 10.3389/fonc.2021.629846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Dabravolski SA, Sukhorukov VN, Kalmykov VA, Orekhov NA, Grechko AV, Orekhov AN. Heat Shock Protein 90 as Therapeutic Target for CVDs and Heart Ageing. Int J Mol Sci 2022;23:649. [PMID: 35054835 DOI: 10.3390/ijms23020649] [Reference Citation Analysis]
2 Yun S, Lee S, Lee HY, Oh HJ, Kwak Y, Lee HS. Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases. Int J Mol Sci 2021;22:7042. [PMID: 34208855 DOI: 10.3390/ijms22137042] [Reference Citation Analysis]
3 Kołat D, Kałuzińska Ż, Bednarek AK, Płuciennik E. Determination of WWOX Function in Modulating Cellular Pathways Activated by AP-2α and AP-2γ Transcription Factors in Bladder Cancer. Cells 2022;11:1382. [PMID: 35563688 DOI: 10.3390/cells11091382] [Reference Citation Analysis]
4 Tao J, Yin L, Wu A, Zhang J, Zhang J, Shi H, Liu S, Niu L, Xu L, Feng Y, Lian S, Li L, Zeng L, Meng X, Zhou X, Liu T, Zhang L. PDIA2 Bridges Endoplasmic Reticulum Stress and Metabolic Reprogramming During Malignant Transformation of Chronic Colitis. Front Oncol 2022;12:836087. [DOI: 10.3389/fonc.2022.836087] [Reference Citation Analysis]
5 Zimmer N, Trzeciak ER, Graefen B, Satoh K, Tuettenberg A. GARP as a Therapeutic Target for the Modulation of Regulatory T Cells in Cancer and Autoimmunity. Front Immunol 2022;13:928450. [DOI: 10.3389/fimmu.2022.928450] [Reference Citation Analysis]
6 Bouchard A, Sikner H, Baverel V, Garnier AR, Monterrat M, Moreau M, Limagne E, Garrido C, Kohli E, Collin B, Bellaye PS. The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with 99mTc-Tilmanocept SPECT. Cells 2021;10:3393. [PMID: 34943901 DOI: 10.3390/cells10123393] [Reference Citation Analysis]
7 Chakraborty A, Edkins AL. HSP90 as a regulator of extracellular matrix dynamics. Biochem Soc Trans 2021:BST20210374. [PMID: 34913470 DOI: 10.1042/BST20210374] [Reference Citation Analysis]
8 Fornasiero F, Scapin C, Vitadello M, Pizzo P, Gorza L. Active nNOS Is Required for Grp94-Induced Antioxidant Cytoprotection: A Lesson from Myogenic to Cancer Cells. Int J Mol Sci 2022;23:2915. [PMID: 35328344 DOI: 10.3390/ijms23062915] [Reference Citation Analysis]
9 Alberti G, Vergilio G, Paladino L, Barone R, Cappello F, Conway de Macario E, Macario AJL, Bucchieri F, Rappa F. The Chaperone System in Breast Cancer: Roles and Therapeutic Prospects of the Molecular Chaperones Hsp27, Hsp60, Hsp70, and Hsp90. IJMS 2022;23:7792. [DOI: 10.3390/ijms23147792] [Reference Citation Analysis]